Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION”

6 pharma patents match "THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION” · 30,257 patents in full index Clear search

  1. US 12234461

    Targeted non-viral DNA insertions

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  2. US 11136301

    Broad spectrum antiviral compounds and uses thereof

    The Regents of the University of California, A California Corporation et al. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  3. US 10654916

    Compositions and methods for the treatment of neuromyelitis optica

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted May 19, 2020 · Expires May 14, 2040

    granted
  4. US 9121852

    Carcinoma diagnosis and treatment, based on ODC1 genotype

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  5. US 8835630

    Acyclic nucleoside phosphonate diesters

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted
  6. US 8329636

    Carcinoma diagnosis and treatment, based on ODC1 genotype

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted